Renovis Surgical Announces FDA Clearance of T700 Cannulated Screw System

— Press Release —

Redlands, CA / Austin, TX (December 9, 2011) – Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the T700™ Cannulated Screw system. As the first offering in the company’s trauma product line, this marks a major milestone for the company.

The T700 Cannulated Screw system was designed to stabilize fractures in the hip, upper and lower extremities, femur and tibia. The system offers a comprehensive array of screws lengths, diameters, and thread lengths. Material options include titanium and stainless steel. The company will also introduce the option of high-strength, low-nickel Biodur® 108 stainless steel.

The company is currently developing additional products across multiple categories, with further offerings in trauma planned, as well as in spine and joint replacement.

About Renovis Surgical
Renovis Surgical Technologies was founded in 2009 with the express mission of creating highest quality implants for orthopedics, spine and trauma, and delivering those implants to the healthcare marketplace at a value. The company is based in Redlands, California, and has engineering and manufacturing operations in Austin, Texas. BioDur® is a registered trademark of CRS Holdings, Inc.

For additional information on the Company, please visit renovis-surgical.com.

# # #

Media Contact: 909.557.2360